| Moffitt

FDA Set to Approve Earlier Use of CAR T for Multiple Myeloma

The treatment is currently approved for patients who fail four lines of treatment

Is Outpatient CAR T Therapy Safe for Multiple Myeloma Patients?

Outpatient treatment significantly reduced average hospital stay to four days, study shows

Cancer Treatment Can Be Hard on the Heart. Moffitt Has a Team for That.

The Cardio-Oncology Program at Moffitt treats patients with a risk of heart issues before, during and after treatment

USF Women’s Basketball Honorary Game Ball Goes to Moffitt Hematologist

Dr. Celeste Bello featured at Play4Kay cancer game

Victory Over Adversity

Bucs equipment director claims victory over a formidable opponent: cancer

New Study Shows Promise in Equalizing Outcomes for Transplant Patients

Post-transplant drug has potential to close racial gap for mismatched donors

New Treatment Reduces Need for Blood Transfusions for Patients with Certain Blood Cancers, Study Shows

Almost 40% of patients with lower risk myelodysplastic syndromes achieved eight-week transfusion independence with imetelstat, study shows

Using Contemporary Data to Better Classify Blood Clot Risk in Polycythemia Vera Patients

Study shows age is less of a factor than medical history when it comes to risk for thrombosis

Already Approved Drug Shows Promise in Patients with MDS/MPN Overlapping Syndromes

Moffitt launched trial investigates myelofibrosis drug in rare patient population

Moffitt's IPOP Service Reduces Time in Hospital

Moffitt's IPOP service allows patients to receive some treatment regimens historically given in an inpatient setting in an outpatient setting.

Save the Body, Lose the Soul

As a Jehovah’s Witness, Naomi Burgess refuses to accept blood products. When she was diagnosed with leukemia, she faced the ultimate test of her faith ...

Teacher Returns to the Classroom after Schooling Cancer

Tarik Mowatt was diagnosed with Hodgkin lymphoma his first year teaching

Molecular Risk Model Better Predicts Outcomes in Rare Blood Cancer

New model can help dictate treatment decisions in chronic myelomonocytic leukemia

‘Jurassic Park’ Actor Shares Angioimmunoblastic T-cell Lymphoma Diagnosis

It’s believed AITL is linked to the Epstein-Barr Virus, but more research is needed

Fast-Paced Research in Field Keeps Hematologist Hopeful for a Cure

Dr. Claudia Paba Prada is an oncologist/hematologist with Moffitt Malignant Hematology and Cellular Therapy at Memorial Healthcare System

High School Biology Lesson Inspires Decades-long Career as Bone Marrow Transplanter

Dr. Lia Perez is a hematologist and researcher who is an expert in allogeneic hematopoietic stem cell transplantation

As COVID-19 Restrictions Loosen, Other Viruses on the Rise

Respiratory viruses are hitting harder and later into the season

Moffitt Researches COVID Vaccine Effectiveness in Cancer Patients

Study finds that antibody levels in patients with cancer were not the same as those in healthy adults who had received two doses of the COVID vaccine

Can Gene-Edited CAR T Improve Non-Hodgkin Lymphoma Outcomes?

New product involves dual targeting, signaling technology and gene editing

Taking Multiple Myeloma Care to ‘Another Level’

A $10 million donation from It Works! founder establishes Pentecost Family Myeloma Research Center

COVID-19 Still a Risk for Patients with Cancer as Cases Rise

New studies look at treatments and vulnerability in cancer population

Former Tour de France Champion Greg LeMond Reveals Leukemia Diagnosis

Chronic myelogenous leukemia is treatable, but not yet curable

Can the Gut Microbiome Predict Response to Cancer Treatment?

New study suggests so for recurrent metastatic head and neck cancer patients

Infectious Disease Expert’s Biggest Challenge: Time

Meet Dr. Olga Klinkova of Internal and Hospital Medicine at Moffitt

Mother’s Colon Cancer Diagnosis Inspires Oncology Career

Meet Dr. Vania Phuoc at Moffitt Cancer Center at Wesley Chapel

Does Intensifying Lymphodepletion Impact CAR T-Cell Therapy?

Study investigates increasing duration and dosage of chemotherapy in patients with B-cell malignancies

Stepping Up to the Plate

At 30, star athlete Jarryd Reid was diagnosed with a rare blood cancer. Being fit just may have saved his life.

Colin Powell Dies of COVID-19 Complications

He also had multiple myeloma at 84, which affected his immune response to the vaccine

Cancer Survivor Chronicles ‘Bad Blood’ Experience in Children’s Book

After her own cancer battle, Kassandra Nealon wanted to help kids understand blood cancer

Pistol Annies Singer Shares Rare Blood Cancer Diagnosis

Waldenström Macroglobulinemia is often asymptomatic but can be treated, according to Moffitt experts

Finding the Match

Two Moffitt trials aim to provide better outcomes for minority bone marrow transplant patients

WrestleMania’s Defending Champion Roman Reigns Talks About Smacking Down Cancer

WWE superstars step out of the ring to spend time with health care heroes

Patient Launches into Dream Job During Cancer Fight

Former Army pilot now works on NASA’s program to go back to the moon

Dr. Brandon Blue is Leading By Example

Being a Black doctor in his hometown community speaks volumes

Blood Counts

A bone marrow transplant from his brother and the love from his wife brought Caleb Morris back to life.

Drug Helps Control Iron Deficiency in Polycythemia Vera Patients

PTG-300 mimics the body’s main regulator of iron absorption

Can UltraCAR-T™ Treat Myeloid Malignancies?

New type of CAR T therapy gets engineered cells to patients quicker

New Combination Therapy Shows Promise for Leukemia Patients

Early phase trial finds magrolimab plus chemotherapy effective in acute myeloid leukemia patients

Jeff Bridges Announces Lymphoma Diagnosis

Remission is possible, depending on the cancer’s biology

The Milestones Behind Miles for Moffitt

How three friends sparked an annual tradition for thousands Social Caption: In 15 years, Miles for Moffitt has become a staple in the Tampa Bay com ...